Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-07-30

Clinical Trial Update: A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating DR-2021 in women with secondary amenorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DR-2021

Snippet

Sponsor: Duramed Research | Conditions: Amenorrhea | Phase 2 | Status: COMPLETED